Ruzurgi (amifampridine) - Authorization Status
RUZURGI (amifampridine), a medication used to treat a rare neuromuscular condition, is being withdrawn from the market in Canada due to new safety information. The product was distributed across Canada. Health authorities have determined that the safety concerns warrant removing this drug from availability.
- Product
- RUZURGI (amifampridine)
- Reason
- New safety information - Product withdrawal
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-01-20
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/b38c405b-f40c-4c2a-9fbf-651df7da890a